Biomed Digital

Wearable technologies and Machine Learning to detect early onsets of Alzheimer's Disease

Diagnosing early onsets of dementia can be a challenge to clinicians. Current diagnostic tools usually cannot identify people in the early stages of disease. By the time patients receive a diagnosis, neurons have died and brain anatomy has changed.

Biomed Digital, LLC. is harnessing the power of wearable or mobile technologies and machine learning. By gathering data from people not yet showing obvious clinical symptoms of cognitive decline, these devices could be used to create a digital phenotype that helps clinicians diagnose dementia early, before neuronal death.

Our researchers used machine learning on the dataset to develop a model to distinguish which people had cognitive impairment and which were healthy, based solely on the pattern of digital data received from the participants’ devices and their responses to iPad tasks.

We follow strict privacy and security measures to protect consumer data such as the US Health Insurance Portability and Accountability Act of 1996 (HIPAA) to protect health information in electronic form.